Evkeeza 150 mg/mL
evinacumab · INJECTION, SOLUTION, CONCENTRATE · Regeneron Pharmaceuticals, Inc.
Evkeeza is a injection, solution, concentrate containing evinacumab at 150 mg/mL, taken intravenous. Manufactured by Regeneron Pharmaceuticals, Inc..
Key Facts
- Brand Name
- Evkeeza
- Generic Name
- evinacumab
- NDC Code (Product)
61755-013- Manufacturer
- Regeneron Pharmaceuticals, Inc.
- Strength
- 150 mg/mL
- Dosage Form
- INJECTION, SOLUTION, CONCENTRATE
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA761181
- Drug Class
- Angiopoietin-like 3 Inhibitor [EPC]
- Marketing Start
- 02/11/2021
Recall History
No Recall HistoryFrequently Asked Questions
What is Evkeeza used for?
Evkeeza contains evinacumab. It is a injection, solution, concentrate taken intravenous. Consult your doctor for specific uses.
Is Evkeeza a controlled substance?
Evkeeza is not classified as a controlled substance by the DEA.
What is the generic name for Evkeeza?
The generic name for Evkeeza is evinacumab. There are no other listed brand versions of evinacumab.
What is the NDC code for Evkeeza 150 mg/mL?
The NDC (National Drug Code) for Evkeeza 150 mg/mL is 61755-013, listed by Regeneron Pharmaceuticals, Inc..
Other Evkeeza Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)